SynthesisBMC gastroenterology2025
Endoscopic ultrasound-guided ethanol vs ethanol combined with paclitaxel for the ablation of pancreatic cystic lesions: a systematic review and meta-analysis.
Synthesis in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSome pancreatic cystic lesions (PCLs) have the risk of malignant transformation, but the complications of pancreatic surgery are high, and minimally invasive treatment is imperative. Endoscopic ultrasound (EUS) -guided ablation has been utilized to treat pancreatic cysts. We undertook the meta-analysis and systematic review to assess the efficacy and safety of this technique in PCLs.
methodsMEDLINE, Embase, Cochrane Library databases were searched for relevant studies reporting on EUS-guided ablation on PCLs with outcomes of interest. The primary outcome was complete cyst resolution rate, and secondary outcome was adverse events rate.
resultsEleven studies (1092 patients with 1093 PCLs) were selected. Pooled complete cyst resolution rate was 52.6% (95%CI: 41.1-64.1%; I
conclusionsEUS-guided ablation appears to be a minimally invasive treatment with an acceptable efficacy and safety. Ethanol-sequenced paclitaxel is superior to ethanol alone in terms of efficacy and safety for PCLs ablation, but there is no statistical difference; more perfect studies are needed to verify these in the future. PROSPERO REGISTRATION NUMBER: CRD42024583031.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.